Erlotinib and haemoptysis 
Erlotinib and haemoptysis Patient Reports February 09, 2010
Erlotinib Side Effects Report #4640610-X
Erlotinib side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastric ulcer haemorrhage, gastric ulcer perforation, haemoptysis, neoplasm progression. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DARBEPOETIN ALFA. Patient was hospitalized. Patient died on 03/20/2005.
Erlotinib Side Effects Report #4693802-8
Erlotinib side effect was reported by a Physician from on May 31, 2005. Male patient, 79 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: gastrointestinal ulcer haemorrhage, gastrointestinal ulcer perforation, haemoptysis, neoplasm progression, post procedural complication. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DARBEPOETIN ALFA. Patient was hospitalized. Patient died on 03/20/2005.
Erlotinib Side Effects Report #6088065-5
Erlotinib side effect was reported by a Physician from JAPAN on Feb 06, 2009. Female patient, 74 years of age, weighting 77.16 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, disease recurrence, haemoptysis. Erlotinib dosage: (100 MG, QD) ,ORAL. During the same period patient was treated with PROTECADIN, MUCOSTA, ASTOMIN. Patient recovered.
Erlotinib Side Effects Report #5285907-8
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 13, 2007. Male patient, 69 years of age, weighting 196.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, body temperature increased, cough, dyspnoea, haemoptysis, lung consolidation, lymphadenopathy, pain
, pericardial effusion. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with DOCETAXEL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5902507-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Sept 11, 2008. Male patient, 69 years of age, weighting 183.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: diarrhoea, disease progression, dyspnoea exertional, haemoptysis, increased upper airway secretion, liver disorder, lung disorder, malaise, nausea
. Erlotinib dosage: (150 MG, QD), ORAL. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5323622-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Apr 23, 2007. Male patient, 68 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: coagulation factor v level increased, coagulation factor viii level increased, dysphagia, haemoptysis, oesophagitis, oral intake reduced, prothrombin level increased, prothrombin time prolonged, vitamin k deficiency. Erlotinib dosage: 100 MG (QD) , ORAL. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, CARBOPLATIN, FENTANYL CITRATE, LIDOCAINE, ZOLPIDEM TARTRATE, FLUCONAZOLE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5217471-3
Erlotinib side effect was reported by a Health Professional from TAIWAN, PROVINCE OF CHINA on Jan 03, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, bronchoscopy abnormal, haemoptysis, lung consolidation, necrosis, pleural effusion, pneumonia
, pneumothorax, pulmonary cavitation. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #5245532-1
Erlotinib side effect was reported by a Physician from TAIWAN, PROVINCE OF CHINA on Feb 02, 2007. Male patient, 67 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchiectasis, bronchoscopy abnormal, disease progression, haemoptysis, lung consolidation, necrosis, pleural effusion, pneumonia
, pneumothorax. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with METFORMIN, GLIMEPIRIDE, MONTELUKAST, TAMSULOSIN, TRIAMCINOLONE, SENNOSIDE, CLARINASE. Patient was hospitalized. Patient died.Erlotinib Side Effects Report #4832421-7
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 02, 2005. Male patient, 66 years of age, weighting 151.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, dehydration, haemoptysis, malignant neoplasm progression, non-small cell lung cancer. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with AVASTIN. Patient died on 11/01/2005.
Erlotinib Side Effects Report #5237023-9
Erlotinib side effect was reported by a Physician from SWEDEN on Jan 26, 2007. Male patient, 64 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood creatinine increased, diarrhoea, haemoptysis, lung neoplasm malignant, malignant neoplasm progression, malnutrition, nausea
, performance status decreased. Erlotinib dosage: 150 MG, ORAL. During the same period patient was treated with OXYCONTIN, PREDNISOLONE, ACETAMINOPHEN, COZAAR, METOPROLOL TARTRATE, KLEXANE, IMOVANE, OXYCODONE. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5530041-2
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 12, 2007. Male patient, 63 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: fall
, haemoptysis, haemorrhage, oesophageal ulcer. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, ANTIFUNGAL, PACLITAXEL, CARBOPLATIN. Patient was hospitalized. Patient died on 10/28/2007.Erlotinib Side Effects Report #5721280-6
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 11, 2008. Female patient, 61 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: blood bilirubin increased, haemoptysis. Erlotinib dosage: (150 MG,QD), ORAL. Patient died.
Erlotinib Side Effects Report #4679762-4
Erlotinib side effect was reported by a Physician from on Mar 18, 2005. Male patient, 60 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: body temperature decreased, dyspnoea exertional, haemoptysis, interstitial lung disease, respiratory disorder, stomatitis. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with TRIAMCINOLONE ACETONIDE. Patient was hospitalized. Patient died on 05/11/2005.
Erlotinib Side Effects Report #4899161-X
Erlotinib side effect was reported by a Health Professional from IRELAND on Jan 13, 2006. Female patient, 58 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, haemoglobin decreased, haemoptysis, red blood cell count decreased. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with ORAMORPH, MYCOSTATIN, NEXIUM, XANAX, MOBIC. Patient was hospitalized. Patient died on 01/05/2006.
Erlotinib Side Effects Report #5147080-6
Erlotinib side effect was reported by a Physician from SWITZERLAND on Oct 18, 2006. Male patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoptysis, hydropneumothorax. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5196246-8
Erlotinib side effect was reported by a Physician from SWITZERLAND on Dec 07, 2006. Male patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoptysis, hydropneumothorax. Erlotinib dosage: 150 MG QD ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5466210-X
Erlotinib side effect was reported by a Physician from SWITZERLAND on Sept 04, 2007. Male patient, 50 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoptysis, hydropneumothorax, malignant neoplasm progression, non-small cell lung cancer. Erlotinib dosage: 150 MG (QD), ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient died on 12/18/2006.
Erlotinib Side Effects Report #5536341-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 19, 2007. Female patient, 47 years of age, weighting 168.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, condition aggravated, haemoptysis, pulmonary hilum mass, tracheal mass. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, CODEINE SUL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5567652-4
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Nov 30, 2007. Female patient, 47 years of age, weighting 168.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, haematocrit decreased, haemoglobin decreased, haemoptysis, red blood cell count increased, tobacco abuse. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with BEVACIZUMAB, LIDOCAINE, CODEINE SUL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5616150-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Jan 18, 2008. Female patient, 47 years of age, weighting 168.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, haemoptysis. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BEVACIZUMAB, LIDOCAINE, CODEINE SUL. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5534248-X
Erlotinib side effect was reported by a Physician from NETHERLANDS on Nov 15, 2007. Female patient, 40 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoptysis, respiratory arrest. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with INDOMETHACIN, KLACID, AUGMENTIN, DOPAMINE, ACTRAPID, HALOPERIDOL, MINRIN, DIPRIVAN. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5578125-7
Erlotinib side effect was reported by a Physician from NETHERLANDS on Dec 18, 2007. Female patient, 40 years of age, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, anxiety
, haemoptysis, respiratory arrest. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with INDOMETHACIN, CLARITHROMYCIN, AUGMENTIN, DOPAMINE, ACTRAPID, MIDAZOLAM, HALOPERIDOL, MINRIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #6120264-6
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Feb 25, 2009. Female patient, 39 years of age, weighting 171.1 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, haemoptysis, platelet count decreased, white blood cell count decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BACTRIM DS, CLINDAMYCIN PHOSPHATE, ALBUTEROL, TYLENOL PM, PREDNISONE, DOCETAXEL, GEMCITABINE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6140493-5
Erlotinib side effect was reported by a Health Professional from UNITED STATES on Mar 16, 2009. Female patient, 39 years of age, weighting 172.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haematocrit decreased, haemoglobin decreased, haemoptysis, thrombocytopenia, white blood cell count decreased. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with BACTRIM DS, CLINDAMYCIN PHOSPHATE, ALBUTEROL, TYLENOL WITH CODEINE, PREDNISONE, GEMCITABINE, ATOVAQUONE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6099698-4
Erlotinib side effect was reported by a Physician from CZECH REPUBLIC on Feb 13, 2009. Male patient, 33 years of age, weighting 202.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoptysis, loss of consciousness. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with DURAGESIC, NIMESULIDE, CITALOPRAM HYDROBROMIDE, FRAXIPARINE. Patient was hospitalized. Patient died on 01/26/2009.
Erlotinib Side Effects Report #5532822-8
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 30, 2007. Male patient, weighting 203.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: chills, cough, dyspnoea, haemoptysis, hypoxia, lung infection, oxygen saturation decreased, pleural effusion, pyrexia. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATINIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5549853-4
Erlotinib side effect was reported by a Physician from UNITED STATES on Dec 06, 2007. Male patient, weighting 203.9 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: computerised tomogram abnormal, cough, dyspnoea, haemoptysis, hypoxia, pleural effusion. Erlotinib dosage: 150MG ORALLY QD. During the same period patient was treated with DASATIB. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5997996-3
Erlotinib side effect was reported by a Physician from UNITED STATES on Nov 14, 2008. Male patient, weighting 128.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, haemoglobin decreased, haemoptysis, hypoxia, international normalised ratio increased, lung consolidation, lymphadenopathy mediastinal, malignant neoplasm progression, prothrombin time prolonged. Erlotinib dosage: (150 MG,GD), ORAL. During the same period patient was treated with SORAFENIB, COUMADIN, MORPHINE, CHLORPROMAZINE, LASIX, DURAGESIC. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #6092991-0
Erlotinib side effect was reported by a Physician from UNITED STATES on Feb 10, 2009. Male patient, weighting 128.0 lb, was diagnosed with non-small cell lung cancer and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: atelectasis, haemoglobin decreased, haemoptysis, hypoxia, malignant neoplasm progression, prothrombin time prolonged. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with COUMADIN, MORPHINE, CHLORPROMAZINE, LASIX, DURAGESIC, APIXTRA. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5787712-2
Erlotinib side effect was reported by a Pharmacist from UNITED STATES on June 24, 2008. Male patient, 54 years of age, weighting 159.2 lb, was diagnosed with lung neoplasm malignant, deep vein thrombosis
and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoptysis, international normalised ratio abnormal, international normalised ratio increased. Erlotinib dosage: 150 MG EVERY DAY PO. During the same period patient was treated with WARFARIN. Patient was hospitalized. Patient recovered.Erlotinib Side Effects Report #5731802-7
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 22, 2008. Female patient, 75 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, haemoptysis, interstitial lung disease, pulmonary alveolar haemorrhage, pyrexia. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with LANIRAPID, VERAPAMIL HYDROCHLORIDE, ZOLPIDEM TARTRATE. Patient was hospitalized. Patient recovered.
Erlotinib Side Effects Report #5731804-0
Erlotinib side effect was reported by a Health Professional from JAPAN on Apr 22, 2008. Female patient, 61 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, haemoptysis, haemorrhage. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MAGNESIUM OXIDE, MORPHINE, ROPION. Patient died on 03/31/2008.
Erlotinib Side Effects Report #5839446-3
Erlotinib side effect was reported by a Physician from JAPAN on Apr 22, 2008. Female patient, 61 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: anaemia, blood bilirubin increased, haemoptysis, metastases to bone, rash
, tumour haemorrhage. Erlotinib dosage: 150 MG, QD, ORAL. During the same period patient was treated with ROPION, MAGNESIUM OXIDE, MORPHINE, MAXIPIME, MIDAZOLAM, CEFIPIME. Patient died on 03/31/2008.Erlotinib Side Effects Report #5862217-9
Erlotinib side effect was reported by a Physician from JAPAN on Aug 12, 2008. Male patient, 53 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchostenosis, cardio-respiratory arrest, disease progression, dyspnoea, haemoptysis, hepatic function abnormal, rash
, shock, white blood cell count decreased. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with MEDICON, MUCOSOLVAN, MUCODYNE, ZOLPIDEM TARTRATE, LOXONIN, HUSTAGIN, APRICOT, CODEINE PHOSPHATE. Patient died on 07/26/2008.Erlotinib Side Effects Report #5891591-2
Erlotinib side effect was reported by a Health Professional from JAPAN on Sept 04, 2008. Male patient, 53 years of age, was diagnosed with lung adenocarcinoma and was treated with Erlotinib. After drug was administered, patient experienced the following side effects: bronchostenosis, cardio-respiratory arrest, disease progression, dry skin, dyspnoea, haemoptysis, haemorrhage, hepatic function abnormal, rash
. Erlotinib dosage: (150 MG,QD), ORAL. During the same period patient was treated with MEDICON, MUCOSOLVAN, MUCODYNE, ZOLPIDEM TARTRATE, LOXONIN, HUSTAGIN, APRICOT, CODEINE PHOPHATE. Patient died on 07/26/2008.Erlotinib Side Effects Report #6051203-4
Erlotinib side effect was reported by a Physician from JAPAN on Jan 05, 2009. Male patient, 79 years of age, weighting 143.3 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: cardio-respiratory arrest, diarrhoea, haemoptysis, rash papular, skin ulcer. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with URINORM, DIART, ALESION, KIPRES, MUCODYNE, ADOAIR, PREDNISOLONE, INTAL. Patient died on 11/02/2008.
Erlotinib Side Effects Report #5984664-7
Erlotinib side effect was reported by a Physician from JAPAN on Nov 18, 2008. Male patient, 78 years of age, weighting 143.3 lb, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: haemoptysis. Erlotinib dosage: (150 MG, QD), ORAL. During the same period patient was treated with URINORM, DIART, ALESION, KIPRES, MUCODYNE, ADOAIR, PREDNISOLONE, INTAL. Patient died on 11/02/2008.
Erlotinib Side Effects Report #5599280-9
Erlotinib side effect was reported by a Consumer or non-health professional from UNITED STATES on Jan 02, 2008. Female patient, 67 years of age, was treated with Erlotinib. After drug was administered, patient experienced the following side effects: arterial thrombosis limb, haemoptysis. Erlotinib dosage: 150 MG, 1 IN 1 D, ORAL. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.